Need for transfusions falls with erythropoietin before surgery

05/9/2013 |

Patients who received human recombinant erythropoietin in the days before heart surgery needed less transfused blood, according to findings presented at a thoracic surgery meeting. The randomized prospective study looked at about 600 cardiac surgery patients. Erythropoietin is a viable but underutilized tool for patient blood management, said Dr. Luca Weltert of the European Hospital in Rome.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID